Polyamines as targets for therapeutic intervention

L. J. Marton, A. E. Pegg

Research output: Contribution to journalReview article

679 Citations (Scopus)

Abstract

Polyamines are ubiquitous cell components essential for normal growth. Compounds interfering with polyamine biosynthesis or function have considerable potential for use as therapeutic agents. Inhibitors of ornithine decarboxylase have been shown to be valuable for the treatment of diseases caused by parasitic protozoa, most notably African sleeping sickness. They may also be useful chemopreventive and antineoplastic agents. Inhibitors of S-adenosyl-methionine decarboxylase also have potential as treatments of these diseases. Protocols minimizing uptake of exogenous polyamines via the polyamine-transport system will probably be needed for the full potential of the inhibitors to be realized. Polyamine analogues, notably those with ethyl or benzyl groups on the terminal nitrogen atoms, have potent antiproliferative activity and are promising agents for the treatment of cancer. These analogues are transported by the polyamine-transport system, and their therapeutic effects are less likely to be blocked by the availability of the exogenous polyamines.

Original languageEnglish (US)
Pages (from-to)55-91
Number of pages37
JournalAnnual Review of Pharmacology and Toxicology
Volume35
StatePublished - Jan 1 1995

Fingerprint

Polyamines
Therapeutic Uses
Therapeutics
Protozoa
African Trypanosomiasis
Parasitic Diseases
Biosynthesis
Cellular Structures
Antineoplastic Agents
Nitrogen
Availability
Atoms
Growth
Neoplasms

All Science Journal Classification (ASJC) codes

  • Toxicology
  • Pharmacology

Cite this

@article{28590d9788d04cc68fb97b7caf5fdbdb,
title = "Polyamines as targets for therapeutic intervention",
abstract = "Polyamines are ubiquitous cell components essential for normal growth. Compounds interfering with polyamine biosynthesis or function have considerable potential for use as therapeutic agents. Inhibitors of ornithine decarboxylase have been shown to be valuable for the treatment of diseases caused by parasitic protozoa, most notably African sleeping sickness. They may also be useful chemopreventive and antineoplastic agents. Inhibitors of S-adenosyl-methionine decarboxylase also have potential as treatments of these diseases. Protocols minimizing uptake of exogenous polyamines via the polyamine-transport system will probably be needed for the full potential of the inhibitors to be realized. Polyamine analogues, notably those with ethyl or benzyl groups on the terminal nitrogen atoms, have potent antiproliferative activity and are promising agents for the treatment of cancer. These analogues are transported by the polyamine-transport system, and their therapeutic effects are less likely to be blocked by the availability of the exogenous polyamines.",
author = "Marton, {L. J.} and Pegg, {A. E.}",
year = "1995",
month = "1",
day = "1",
language = "English (US)",
volume = "35",
pages = "55--91",
journal = "Annual Review of Pharmacology and Toxicology",
issn = "0362-1642",
publisher = "Annual Reviews Inc.",

}

Polyamines as targets for therapeutic intervention. / Marton, L. J.; Pegg, A. E.

In: Annual Review of Pharmacology and Toxicology, Vol. 35, 01.01.1995, p. 55-91.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Polyamines as targets for therapeutic intervention

AU - Marton, L. J.

AU - Pegg, A. E.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - Polyamines are ubiquitous cell components essential for normal growth. Compounds interfering with polyamine biosynthesis or function have considerable potential for use as therapeutic agents. Inhibitors of ornithine decarboxylase have been shown to be valuable for the treatment of diseases caused by parasitic protozoa, most notably African sleeping sickness. They may also be useful chemopreventive and antineoplastic agents. Inhibitors of S-adenosyl-methionine decarboxylase also have potential as treatments of these diseases. Protocols minimizing uptake of exogenous polyamines via the polyamine-transport system will probably be needed for the full potential of the inhibitors to be realized. Polyamine analogues, notably those with ethyl or benzyl groups on the terminal nitrogen atoms, have potent antiproliferative activity and are promising agents for the treatment of cancer. These analogues are transported by the polyamine-transport system, and their therapeutic effects are less likely to be blocked by the availability of the exogenous polyamines.

AB - Polyamines are ubiquitous cell components essential for normal growth. Compounds interfering with polyamine biosynthesis or function have considerable potential for use as therapeutic agents. Inhibitors of ornithine decarboxylase have been shown to be valuable for the treatment of diseases caused by parasitic protozoa, most notably African sleeping sickness. They may also be useful chemopreventive and antineoplastic agents. Inhibitors of S-adenosyl-methionine decarboxylase also have potential as treatments of these diseases. Protocols minimizing uptake of exogenous polyamines via the polyamine-transport system will probably be needed for the full potential of the inhibitors to be realized. Polyamine analogues, notably those with ethyl or benzyl groups on the terminal nitrogen atoms, have potent antiproliferative activity and are promising agents for the treatment of cancer. These analogues are transported by the polyamine-transport system, and their therapeutic effects are less likely to be blocked by the availability of the exogenous polyamines.

UR - http://www.scopus.com/inward/record.url?scp=0028956729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028956729&partnerID=8YFLogxK

M3 - Review article

C2 - 7598507

AN - SCOPUS:0028956729

VL - 35

SP - 55

EP - 91

JO - Annual Review of Pharmacology and Toxicology

JF - Annual Review of Pharmacology and Toxicology

SN - 0362-1642

ER -